Iqvia Holdings (IQV) Cash from Investing Activities (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Cash from Investing Activities came in at -$196.0 million in Q1 2026, up 35.74% year-on-year from -$144.4 million in Q1 2025, and up 82.25% quarter-over-quarter from -$1.1 billion in Q4 2025.
Iqvia Holdings (IQV) Cash from Investing Activities (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Cash from Investing Activities across 15 years of filings, most recently posting -$196.0 million for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$196.0 million, up 35.74% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.2 billion (down 53.03% YoY), and the FY2025 annual result was -$2.3 billion, down 59.63% from the prior year.
- Cash from Investing Activities came in at -$196.0 million for Q1 2026 at Iqvia Holdings, up from -$1.1 billion in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$196.0 million in Q1 2026 to a low of -$1.1 billion in Q4 2025.
- The 5-year median for Cash from Investing Activities is -$346.0 million (2025), against an average of -$444.4 million.
- Across the five-year window, Cash from Investing Activities soared 63.78% in 2023 and sank 256.13% in 2025, its largest moves.
- Iqvia Holdings' Cash from Investing Activities stood at -$477.0 million in 2022, then soared by 55.56% to -$212.0 million in 2023, then plunged by 46.23% to -$310.0 million in 2024, then tumbled by 256.13% to -$1.1 billion in 2025, then soared by 82.25% to -$196.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$196.0 million (Q1 2026), -$1.1 billion (Q4 2025), and -$550.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | -196.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -32.14 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | -152.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -196.00 Mn |
| Mar 31, 2026 | -196.00 Mn |
| Dec 31, 2025 | -1.10 Bn |
| Dec 31, 2025 | -1.10 Bn |
| Sep 30, 2025 | -550.00 Mn |
| Sep 30, 2025 | -550.00 Mn |
| Jun 30, 2025 | -346.00 Mn |
| Jun 30, 2025 | -346.00 Mn |
| Mar 31, 2025 | -305.00 Mn |
| Mar 31, 2025 | -305.00 Mn |
| Dec 31, 2024 | -310.00 Mn |
| Dec 31, 2024 | -310.00 Mn |
| Sep 30, 2024 | -599.00 Mn |
| Sep 30, 2024 | -599.00 Mn |
| Jun 30, 2024 | -221.00 Mn |
| Jun 30, 2024 | -221.00 Mn |
| Mar 31, 2024 | -314.00 Mn |
| Mar 31, 2024 | -314.00 Mn |
| Dec 31, 2023 | -212.00 Mn |
| Dec 31, 2023 | -212.00 Mn |